tiprankstipranks
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
US Market
BCYC
Bicycle Therapeutics
RESEARCH TOOLSreports

Bicycle Therapeutics (BCYC) Stock News & Sentiment

408 Followers
Bicycle Therapeutics: Portfolio Refocus and Cost Cuts Extend Cash Runway, Strengthening Risk‑Reward and Supporting Buy Rating
Premium
Ratings
Bicycle Therapeutics: Portfolio Refocus and Cost Cuts Extend Cash Runway, Strengthening Risk‑Reward and Supporting Buy Rating
11d ago
BCYC
BCYC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
BCYC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
BCYC
Bicycle Therapeutics Sets 2026 Oncology and Radiopharma Priorities
Premium
Company Announcements
Bicycle Therapeutics Sets 2026 Oncology and Radiopharma Priorities
3M ago
8K
BCYC
Buy Rating for Bicycle Therapeutics: Strong Upside Potential Amid Clinical and Financial Developments
Premium
Ratings
Buy Rating for Bicycle Therapeutics: Strong Upside Potential Amid Clinical and Financial Developments
5M ago
BCYC
Bicycle Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Bicycle Therapeutics Reports Q3 2025 Financial Results
5M ago
BCYC
Strategic Regulatory Alignment and Positive Momentum Justify Buy Rating for Bicycle Therapeutics
Premium
Ratings
Strategic Regulatory Alignment and Positive Momentum Justify Buy Rating for Bicycle Therapeutics
5M ago
BCYC
Bicycle Therapeutics Expands Board with New Appointments
Premium
Company Announcements
Bicycle Therapeutics Expands Board with New Appointments
7M ago
8K
BCYC
More BCYC News >

BCYC News on the Web

Top Executives Quietly Cash Out at Bicycle Therapeutics
TipRanks News
Bearish
Bicycle Therapeutics: Portfolio Refocus and Cost Cuts Extend Cash Runway, Strengthening Risk‑Reward and Supporting Buy Rating
TipRanks News
Neutral
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)
Zacks
Bullish
Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks
Bullish
Bicycle Therapeutics price target lowered to $7 from $11 at RBC Capital
TipRanks News
Bearish
Bicycle Therapeutics price target lowered to $36 from $44 at Oppenheimer
TipRanks News
Bearish
RBC Capital Sticks to Their Hold Rating for Bicycle Therapeutics (BCYC)
TipRanks News
Bearish
Analysts’ Top Healthcare Picks: GRAIL Inc (GRAL), Bicycle Therapeutics (BCYC)
TipRanks News
Neutral

News Score - Last 7 Days

Negative
BCYC
Sector Average
Media Buzz
This Week1 articles
Weekly Average3 articles
News Sentiment
This Week0%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BCYC’s Media Buzz Sentiment?
1 articles about BCYC were published this week. In an average week, 3 articles are published.
    What is BCYC’s weekly average amount of articles?
    In an average week, 3 articles about BCYC are published.
      What is BCYC’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      VCELVericel
      NBIXNeurocrine
      ANGOAngioDynamics
      ADAGAdagene
      ORICOric Pharmaceuticals
      Showing the stocks with the most bullish news sentiment over the past week